34-member consortium creates an interoperable data standard for AI and distributed analytics Notable founding members include Guardant Health, NetApp,...
New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies...
1 Growth Stock with All-Star Potential and 2 That Underwhelm
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 21, 2025, the Compensation Committee of Guardant’s Board of Directors approved the granting of...
Tissue-free Guardant Reveal test identifies disease progression up to 18 months earlier than standard clinical measures in patients with advanced cancer ...
Stocks making big moves yesterday: Clover Health, Rivian, Johnson Controls, Kratos, and Guardant Health
Published study adds to growing evidence that the Shield blood-based screening test boosts adherence
Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of an upsized underwritten public offering of 3,333,333 shares of Guardant...